Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kallieri, M., Zervas E., Katsoulis K., Fouka E., Porpodis K., Samitas K., et al. (2020).  Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis.. Int Arch Allergy Immunol. 181(8), 613-617.
Kallianos, A., Rapti A., Zarogoulidis P., Tsakiridis K., Mpakas A., Katsikogiannis N., et al. (2013).  Therapeutic procedure in small cell lung cancer.. J Thorac Dis. 5 Suppl 4, S420-4.
Kallianos, A., Tsimpoukis S., Zarogoulidis P., Darwiche K., Charpidou A., Tsioulis I., et al. (2013).  Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today.. Onco Targets Ther. 6, 609-13.
Kallianos, A., Panoutsopoulos A., Mermigkis C., Kostopoulos K., Papamichail C., Kokkonouzis I., et al. (2015).  Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome.. Clin Interv Aging. 10, 1361-6.
Kallianos, A., Velentza L., Zarogoulidis P., Baka S., Kosmidis C., Labaki S., et al. (2017).  Progressive dyspnea due to pulmonary carcinoid tumorlets.. Respir Med Case Rep. 21, 84-85.
Kallianos, A., Zarogoulidis P., Ampatzoglou F., Trakada G., Gialafos E., Pitsiou G., et al. (2015).  Reduction of exercise capacity in sarcoidosis in relation to disease severity.. Patient Prefer Adherence. 9, 1179-88.
Kallaras, K., Babas G., Stergiou-Michailidou V., Karamouzis M., & Zaraboukas T. (2009).  Atrial natriuretic peptide decreases aorta stiffness in cholesterol-fed anesthetized rabbits.. Pharmacol Res. 60(4), 324-31.
Kalkanis, A., Kalkanis D., Drougas D., Vavougios G. D., Datseris I., Judson M. A., et al. (2016).  Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis.. Nucl Med Commun. 37(3), 273-7.
Kalkan, U., Yoldemir T., Ozyurek E. S., & Daniilidis A. (2017).  Native tissue repair versus mesh repair in pelvic organ prolapse surgery.. Climacteric. 20(6), 510-517.
Kalkan, Ü., & Daniilidis A. (2019).  Laparoscopic Diagnosis and Treatment of Obturator Nerve Entrapment Because of a Deep Infiltrating Endometriotic Nodule: A Case Report.. J Minim Invasive Gynecol. 26(4), 766-769.
Kaliyadan, F., Jayasree P., Kuruvilla J., Errichetti E., & Lallas A. (2020).  The use of blue light, multispectral dermoscopy in vitiligo: A pilot study.. Skin Res Technol. 26(4), 612-614.
Kaliyadan, F., Errichetti E., Lallas A., Swaroop K., & Alabdulsalam A. (2020).  Dermoscopy of idiopathic atrophoderma of Pasini and Pierini.. Australas J Dermatol. 61(1), e120-e122.
Kalinderis, M., Papanikolaou A., Kalinderi K., Vyzantiadis T-A., Ioakimidou A., & Tarlatzis B. C. (2015).  Serum levels of leptin and IP-10 in preeclampsia compared to controls.. Arch Gynecol Obstet. 292(2), 343-7.
Kalinderis, M., Papanikolaou A., Kalinderi K., Ioannidou E., Giannoulis C., Karagiannis V., et al. (2011).  Elevated serum levels of interleukin-6, interleukin-1β and human chorionic gonadotropin in pre-eclampsia.. Am J Reprod Immunol. 66(6), 468-75.
Kalinderi, K., Bostantjopoulou S., Katsarou Z., Clarimón J., & Fidani L. (2012).  Lack of association of the PICALM rs3851179 polymorphism with Parkinson's disease in the Greek population.. Int J Neurosci. 122(10), 502-605.
Kalinderi, K., Bostantjopoulou S., Paisan-Ruiz C., Katsarou Z., Hardy J., & Fidani L. (2009).  Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.. Neurosci Lett. 452(2), 87-9.
Kalinderi, K., Fidani L., Katsarou Z., Clarimón J., Bostantjopoulou S., & Kotsis A. (2011).  GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.. Neurobiol Aging. 32(3), 546.e1-5.
Kalinderi, K., Bostantjopoulou S., Katsarou Z., Clarimón J., & Fidani L. (2012).  Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population.. Genet Test Mol Biomarkers. 16(8), 974-7.
Kalinderi, K., Delkos D., Kalinderis M., Athanasiadis A., & Kalogiannidis I. (2018).  Urinary tract infection during pregnancy: current concepts on a common multifaceted problem.. J Obstet Gynaecol. 38(4), 448-453.
Kalinderi, K., Fragakis N., Sotiriadou M., Oriol D-I., Katritsis D., Letsas K., et al. (2018).  PRRX1 Rs3903239 polymorphism and atrial fibrillation in a Greek population.. Hellenic J Cardiol.
Kalinderi, K., Fidani L., & Bostantjopoulou S. (2009).  From 1997 to 2007: a decade journey through the H1 haplotype on 17q21 chromosome.. Parkinsonism Relat Disord. 15(1), 2-5.
Kalinderi, K., Fidani L., Katsarou Z., & Bostantjopoulou S. (2011).  Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.. Int J Clin Pract. 65(12), 1289-94.
Kalifatidis, A., Albanidou-Farmaki E., Daniilidis M., Markopoulos A. K., Karyotis N., & Antoniades D. Z. (2010).  HLA alleles and fissured tongue.. Int J Immunogenet. 37(6), 509-11.
Kalifatidis, A., Lazaridis G., Baka S., Mpoukovinas I., Karavasilis V., Kioumis I., et al. (2015).  Thoracocentesis: from bench to bed.. J Thorac Dis. 7(Suppl 1), S1-4.
Kalfagiannis, N., Siozios A., Bellas D. V., Toliopoulos D., Bowen L., Pliatsikas N., et al. (2016).  Selective modification of nanoparticle arrays by laser-induced self assembly (MONA-LISA): putting control into bottom-up plasmonic nanostructuring.. Nanoscale. 8(15), 8236-44.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.